Vaccination

More than 70% of parents of children with asthma said they in favor of the influenza vaccine during the COVID-19 pandemic.

The data shows booster shots offer particularly strong protection against the variant.

Investigators found about 70% of rheumatology patients had a good antibody response to the COVID-19 vaccines.

The recombinant vaccine resulted in higher rates of seroprotection in all subjects, particularly those 45 years and older.

The vaccine design reduces the amount of antigen required to produce an immune response.

Earlier today the FDA authorized booster doses for the Pfizer or Moderna vaccine for all adults.

Investigators found 11.9% of patients with IBD in a survey were considered vaccine hesitant.

An estimated 23% of healthcare personnel contract influenza annually.

The new indication makes the quadrivalent Seqirus flu shot available for every US-eligible patient age group.

Risky sexual behavior is the sole independent predictor of acute HDV.

Michael Greenberg, MD, MPH, and Rick Nettles, MD, join Lungcast to discuss COVID-19 vaccine development, the 2021-22 flu season, RSV outbreaks, and more respiratory viruses.

The VRBPAC voted 16-2 against the booster dose because of unclear evidence regarding the need.

Hospitals that use the 3-dose vaccine would spend approximately 37% more on prophylaxis for hepatitis B.

Grade 3 injection site redness led to the predefined stopping rules for 10 patients in the clinical trials.

Investigators report that the small number of adverse events from the vaccine were successfully treated, with the remaining participants experiencing no allergic responses.

Though operating room-based injections are predominantly performed, investigators could not find sufficient data that confirmed it as the only safe injection site.

The BNT162b2 vaccine is the first to be approved by the FDA, and will likely result in greater prescribing capability and workplace vaccine mandates.

There was little difference in hospitalization and mortality rates between vaccinated schizophrenia patients and vaccinated control patients.

Would mark the first COVID-19 vaccine to gain full FDA approval.

Research showed that the second dose of the COVID-19 vaccine was well tolerated by patients who experienced allergic reactions from their first dose.

FlowMetric, Inc., discusses its VaxEffect, an immune monitoring platform and how it can be used to measure COVID-19 vaccine responses.

Telemedicine could be useful if it is added to regimen of in-person health care visits.

Researchers push for transparency between health care professionals and patients with diabetes about the safety and efficacy of the influenza vaccine

The vaccines did not result in reductions in semen volume, sperm concentration, sperm motility, and total motile sperm count.

Africa sees third wave as only 1% of the population is fully vaccinated.